A case of lupus-like syndrome in a patient receiving adalimumab and a brief review of the literature on drug-induced lupus erythematosus
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu kazuistiky, časopisecké články, přehledy
PubMed
28191663
DOI
10.1111/jcpt.12506
Knihovny.cz E-zdroje
- Klíčová slova
- anti-TNF treatment, drug-induced lupus erythematosus, lupus-like syndrome, ustekinumab,
- MeSH
- adalimumab aplikace a dávkování škodlivé účinky MeSH
- antiflogistika aplikace a dávkování škodlivé účinky MeSH
- dospělí MeSH
- lidé MeSH
- psoriáza farmakoterapie patologie MeSH
- stupeň závažnosti nemoci MeSH
- systémový lupus erythematodes chemicky indukované MeSH
- TNF-alfa antagonisté a inhibitory MeSH
- ustekinumab terapeutické užití MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- přehledy MeSH
- Názvy látek
- adalimumab MeSH
- antiflogistika MeSH
- TNF-alfa MeSH
- ustekinumab MeSH
WHAT IS KNOWN AND OBJECTIVE: Drug-induced lupus erythematosus occurs with some drugs and resolves with their withdrawal. Anti-TNF therapies have been found to be associated with a lupus-like syndrome, which is clinically distinct from classical drug-induced as well as idiopathic lupus erythematosus. CASE DESCRIPTION: We describe a case of a patient with severe psoriasis, who developed muscle pain with paraesthesia accompanied by ANA titres elevation with adalimumab treatment. The condition resolved after adalimumab cessation, and the patient was started on ustekinumab with good results. WHAT IS NEW AND CONCLUSION: Ustekinumab might be a useful treatment option for patients with a history of TNF-induced lupus-like syndrome.
Citace poskytuje Crossref.org
